PainTEQ Acquires Three U S Patents for Innovative Sacroiliac (SI) Joint Procedure apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
SAN DIEGO, May 27, 2021 /PRNewswire/ NeuraLace Medical, Inc., a medical device company focused on improving pain relief among patients suffering from debilitating chronic nerve pain, announced today that the first patient has been enrolled as part of the AXON-RCT U.S. study: a prospective, randomized, controlled clinical trial comparing the safety and effectiveness of Axon Therapy® for post-traumatic peripheral neuropathic pain to conventional medical management. The Primary Investigator of the study will be Dr. Leonardo Kapural of the Carolinas Pain Institute. We are incredibly excited to start our Axon-RCT study with Dr. Kapural s team to begin testing Axon Therapy on patients that suffer from chronic peripheral nerve pain, said Shiv Shukla, Founder and CEO of NeuraLace Medical.
First Patient Treated in Landmark U S Randomized Clinical Trial of NeuraLace s Chronic Pain Treatment streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
PainTEQ Exceeds 75% Enrollment in Landmark SI Joint Fusion Study
Patient enrollment nears completion in investigational study expanding research of sacroiliac joint dysfunction treatment using a novel therapeutic device.
News provided by
Share this article
Share this article
TAMPA, Fla., March 15, 2021 /PRNewswire/ In the wave of innovative medical technology, PainTEQ, in partnership with Evolve Restorative Center in Santa Rosa, California and Celeri Health in Wilmington, Delaware, quickly nears enrollment completion of their single-arm multicenter prospective study exploring SI joint fusion using PainTEQ s posterior approach.
Enrollment continues for patients who have been treated for SI joint dysfunction using the LinQ™ Sacroiliac Joint Fusion System, a potential new standard of care for patients who have not responded to conservative SI joint treatments. PainTEQ s LinQ is a minimally-invasive treatment for patients with chronic SI joint pain, making it a more attractiv
PainTEQ Exceeds 75% Enrollment in Landmark SI Joint Fusion Study prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.